Bacillus Calmette-Guerin therapy in non-muscle-invasive bladder carcinoma after renal transplantation for end-stage aristolochic acid nephropathy

Aristolochic Acid Nephropathy ◽

Muscle Invasive ◽

End Stage

Long-Term Intravesical Adjuvant Chemotherapy Further Reduces Recurrence Rate Compared with Short-Term Intravesical Chemotherapy and Short-Term Therapy with Bacillus Calmette-Guérin (BCG) in Patients with Non–Muscle-Invasive Bladder Carcinoma

European Urology ◽

10.1016/j.eururo.2007.02.063 ◽

2007 ◽

Vol 52 (4) ◽

pp. 1123-1130 ◽

Cited By ~ 82

Author(s):

Martin G. Friedrich ◽

Uwe Pichlmeier ◽

Hartwig Schwaibold ◽

Stefan Conrad ◽

Hartwig Huland

Keyword(s):

Adjuvant Chemotherapy ◽

Recurrence Rate ◽

Bladder Carcinoma ◽

Intravesical Chemotherapy ◽

Term Therapy ◽

Short Term ◽

Short Term Therapy ◽

1107 15-year outcome of patients with frequently recurrent non-muscle-invasive bladder carcinoma (NMIBC) treated with 5 weekly mitomycin C (MMC) instillations followed by monthly Bacillus-Calmette Guerin (BCG) or alternating BCG and interferon-α2b (IFN) instillations

European Urology Supplements ◽

10.1016/s1569-9056(14)61087-3 ◽

2014 ◽

Vol 13 (1) ◽

pp. e1107 ◽

Cited By ~ 2

Author(s):

R. Järvinen ◽

E. Kaasinen ◽

E. Rintala ◽

T. Liukkonen ◽

V-M. Puolakka ◽

...

Keyword(s):

Mitomycin C ◽

Bladder Carcinoma ◽

Muscle Invasive ◽

Interferon Α2b

Aristolochic acid nephropathy due to herbal drug intake manifested differently as Fanconi’s syndrome and end-stage renal failure – a 7-year follow-up

Clinical Nephrology ◽

10.5414/cnp70537 ◽

2008 ◽

Vol 70 (12) ◽

pp. 537-541 ◽

Cited By ~ 8

Author(s):

P.-I. Kong ◽

Y.-W. Chiu ◽

M.-C. Kuo ◽

S.-C. Chen ◽

J.-M. Chang ◽

...

Keyword(s):

Renal Failure ◽

Aristolochic Acid ◽

Drug Intake ◽

Herbal Drug ◽

End Stage Renal Failure ◽

Fanconi’S Syndrome ◽

Aristolochic Acid Nephropathy ◽

End Stage ◽

Fanconi's Syndrome

Re: Sequential Intravesical Mitomycin plus Bacillus Calmette-Guérin for Non-Muscle-Invasive Urothelial Bladder Carcinoma: Translational and Phase I Clinical Trial

The Journal of Urology ◽

10.1016/j.juro.2016.06.035 ◽

2016 ◽

Vol 196 (3) ◽

pp. 688-689

Author(s):

Sam S. Chang

Keyword(s):

Clinical Trial ◽

Phase I ◽

Bladder Carcinoma ◽

Phase I Clinical Trial ◽

Urothelial Bladder Carcinoma ◽

Urothelial Bladder ◽

Re: Long-Term Outcome of Patients with Frequently Recurrent Non-Muscle-Invasive Bladder Carcinoma Treated with One Perioperative plus Four Weekly Instillations of Mitomycin C followed by Monthly bacillus Calmette-Guérin (BCG) or Alternating BCG and Interferon-α2b Instillations: Prospective Randomised FinnBladder-4 Study

The Journal of Urology ◽

10.1016/j.juro.2016.12.044 ◽

2017 ◽

Vol 197 (3 Part 1) ◽

pp. 605-606

Author(s):

Sam S. Chang

Keyword(s):

Mitomycin C ◽

Bladder Carcinoma ◽

Term Outcome ◽

Long Term Outcome ◽

Muscle Invasive ◽

Interferon Α2b

De novo Urothelial Carcinoma in Kidney Transplantation Patients with End-Stage Aristolochic Acid Nephropathy in China

Urologia Internationalis ◽

10.1159/000230024 ◽

2009 ◽

Vol 83 (2) ◽

pp. 200-205 ◽

Cited By ~ 9

Author(s):

Ming Yuan ◽

Bing-Yi Shi ◽

Han-Zhong Li ◽

Ming Xia ◽

Yong Han ◽

...

Keyword(s):

Kidney Transplantation ◽

Urothelial Carcinoma ◽

Aristolochic Acid ◽

De Novo ◽

Aristolochic Acid Nephropathy ◽

End Stage

Intravesical Bacillus Calmette-Guérin Versus Combination of Epirubicin and Interferon-α2a in Reducing Recurrence of Non–Muscle-invasive Bladder Carcinoma: FinnBladder-6 Study

European Urology ◽

10.1016/j.eururo.2016.03.034 ◽

2016 ◽

Vol 70 (2) ◽

pp. 341-347 ◽

Cited By ~ 11

Author(s):

Timo Marttila ◽

Riikka Järvinen ◽

Tapani Liukkonen ◽

Erkki Rintala ◽

Peter Boström ◽

...

Keyword(s):

Bladder Carcinoma ◽

Interferon Α2a ◽

Polyamine-modulated Factor-1 Methylation Predicts Bacillus Calmette-Guérin Response in Patients with High-grade Non–muscle-invasive Bladder Carcinoma

European Urology ◽

10.1016/j.eururo.2012.05.050 ◽

2013 ◽

Vol 63 (2) ◽

pp. 364-370 ◽

Cited By ~ 17

Author(s):

Miguel Alvarez-Múgica ◽

Jesus M. Fernández-Gómez ◽

Virginia Cebrian ◽

Florentino Fresno ◽

Safwan Escaf ◽

...

Keyword(s):

Bladder Carcinoma ◽

High Grade ◽

Long-term Outcome of Patients with Frequently Recurrent Non–muscle-invasive Bladder Carcinoma Treated with One Perioperative Plus Four Weekly Instillations of Mitomycin C Followed by Monthly Bacillus Calmette-Guérin (BCG) or Alternating BCG and Interferon-α2b Instillations: Prospective Randomised FinnBladder-4 Study

European Urology ◽

10.1016/j.eururo.2015.02.022 ◽

2015 ◽

Vol 68 (4) ◽

pp. 611-617 ◽

Cited By ~ 18

Author(s):

Riikka Järvinen ◽

Timo Marttila ◽

Eero Kaasinen ◽

Erkki Rintala ◽

Sirpa Aaltomaa ◽

...

Keyword(s):

Mitomycin C ◽

Bladder Carcinoma ◽

Term Outcome ◽

Long Term Outcome ◽

Muscle Invasive ◽

Interferon Α2b

Sequential Intravesical Mitomycin plus Bacillus Calmette–Guérin for Non–Muscle-Invasive Urothelial Bladder Carcinoma: Translational and Phase I Clinical Trial

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-14-1781 ◽

2014 ◽

Vol 21 (2) ◽

pp. 303-311 ◽

Cited By ~ 15

Author(s):

Robert S. Svatek ◽

Xiang Ru. Zhao ◽

Edwin E. Morales ◽

Mithilesh K. Jha ◽

Timothy Y. Tseng ◽

...

Keyword(s):

Clinical Trial ◽

Phase I ◽

Bladder Carcinoma ◽

Phase I Clinical Trial ◽

Urothelial Bladder Carcinoma ◽

Urothelial Bladder ◽